Subscribe To Our Free Newsletter |
Biocon Biologics gains FDA approval for Yesafili, shares up
The shares were up by 1.33% to ₹308.75 at 10.40 am on the BSE.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!